l e e n z y m e cyclooxygenase-2 (COX-2) via activation of nuclear factor kappaB (NFκB), and consequently provokes prostaglandin E 2 (PGE 2 ) synthesis, which induces inflammatory responses. In this study, the contribution of protein kinase C (PKC) to IL-1β-induced PGE 2 synthesis in human gingival fibroblasts was investigated. The PKC activator phorbol 12-myristate 13-acetate (PMA) stimulated PGE 2 release and COX-2 mRNA expression, as shown in human gingival fibroblasts stimulated by IL-1β. However, PMA showed only a weak effect on the formation of COX-2-NFκB DNAprotein complex, whereas IL-1β had a clearly stimulatory effect. In cells in which PMA-dependent PKC was down-regulated, PMA failed to induce the formation of NFκB DNA-protein complex and reduced the release of PMA-induced PGE 2 , whereas IL-1β stimulated the formation of COX-2-NFκB DNA-protein complex and PGE 2 release. The atypical PKC (aPKC) inhibitor Gö6983 clearly suppressed the formation of COX-2-NFκB DNA-protein complex and PGE 2 release stimulated by IL-1β but not the inhibitor of conventional PKC (cPKC) and the novel PKC (nPKC) inhibitor Gö6976. These observations suggest that aPKC is involved in IL-1β-induced PGE 2 synthesis, which is controlled by transcription of the COX-2 gene via the 
Introduction
In human gingival fibroblasts, augmentation of prostaglandin E 2 (PGE 2 ) synthesis and release has been considered to be a prominent feature of inflammatory reactions (1, 2) , since elevated levels of PGE 2 are detected in inflamed gingival tissues and crevicular fluid, especially from periodontal sites exhibiting recent attachment loss (3) . Cyclooxygenase (COX) is a rate-limiting enzyme of prostanoid biosynthesis and exists as a constitutive isoform (COX-1), responsible for physiological levels of prostaglandins and as an inducible COX-2 encoded by an immediate early gene, which is rapidly induced after proinflammatory stimuli. COX-2 is expressed by inflammatory cells and is responsible for the high levels of prostaglandins in acute and chronic inflammation (4, 5) . Interleukin-1β (IL-1β), a multifunctional pro-inflammatory cytokine, has been demonstrated to play an important role in the expressional regulation of many genes involved in the inflammatory process (6, 7) . We have previously demonstrated that IL-1β and TNF-α stimulate the expression of COX-2 mRNA and PGE 2 release in human gingival fibroblasts (8, 9) .
It has been shown that the IL-1β-mediated transcription of COX-2 is regulated by many factors, such as extracellular signal-regulated protein kinase (ERK) (10) , the NFκB signaling pathway (11) and protein kinase C (PKC) (12) (13) (14) . However, the signaling pathways of IL-1β-induced 
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COX-2 expression are very complex. Therefore, it is important to clarify the signaling process of IL-1β-mediated COX-2 expression in human gingival fibroblasts. In this study, the roles of PKC and transcriptional activity of NFκB in IL-1β-mediated COX-2 expression and PGE 2 release in human gingival fibroblast were investigated using several inhibitors for the PKC family. Cell culture D-MEM supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin was used for cell culture. Samples of normal gingival tissue were obtained from three healthy individuals undergoing third-molar extraction. Human gingival fibroblasts were cultured using the methods described previously (15) . When the cells surrounding the tissue explants had become confluent, they were detached with 0.05% trypsin and 0.02% EDTA in Hanks' balanced salt solution, and transferred to a tissue culture flask for subculture. The cells were used for the experiments between the 5th and 10th passages. This study was approved by the ethics committee of Nihon University School of Dentistry at Matsudo (No. EC 03-041).
Materials and Methods

Materials
RT-PCR
Total RNA was isolated using RNeasy. RT-PCR was performed using Super Script One-Step RT-PCR with Platinum Taq System. Primers were synthesized on the basis of the reported human cDNA sequence for COX-2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (16, 17) . Sequence of the primers used for RT-PCR were as follows: COX-2, 5′-ATGAGATTGTGGAAAAATTGCT-3′ (forward) and 5′-GATCATCTCTGCCTGAGTATC-3′ (reverse); GAPDH, 5′-CCACCCATGGCAAATTCCATGGCA (forward) and; 5′-TCTAGACGGCAGGTCAGGTCCACC-3′ (reverse). The PCR reactions were performed in a final volume of 50 µl, which contained 25 µl of reaction mixture, 1 µg total RNA, 10 µM each forward and reverse primer, and 1 µl TaqMix. A two-step cycling program was used, and this consisted of an initial template melting step at 94°C for 2 min, denaturation at 94°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 30 s (22 cycles) and a final extension at 72°C for 10 min (18) . After amplification, 10 µl of each reaction mixture was subjected to 2% agarose gel electrophoresis (0.5× Tri-borate buffer) and visualized by ethidium bromide staining under UV light. The relative amount of PCR product was normalized to the corresponding amount of GAPDH PCR product. The PCR products for COX-2 and GAPDH were 310 bp and 598 bp, respectively.
Measurement of PGE 2
Human gingival fibroblasts were cultured in 24-well culture plates in D-MEM containing 10% FCS. When the cells had become confluent, they were deprived of serum for 18 h to prevent further extracellular stimulation, and then IL-1β or PMA was added. The medium was collected after various time intervals and the amount of PGE 2 was determined by enzyme immunoassay using a commercially available kit (18) .
Gel mobility shift assay
Confluent human gingival fibroblasts in T-75 flasks incubated for 60 min with IL-1β or PMA in D-MEM without serum were used to prepare nuclear extracts. Nuclear protein was extracted by the method of Digman et al. (19) with the addition of extra proteinase inhibitors (the extraction buffer was 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM dithiothreitol (DTT), 0.25% (V/V) glycerol, 0.5 mM phenylmethylsulfonyl fluoride, 2 µg/ml leupeptin, 2 µg/ml pepstatin, and 1µg/ml apotinin, pH 7.9). Double-stranded oligonucleotides corresponding to the NFκB motif (COX-2-NFκB; -230 to -207) (5′-GAGAGTGGGGACTACCCCCTCTGC) in the human COX-2 gene promoter (20) were end-labeled with [γ-32 P]ATP using T4 polynucleotide kinase, and the product at 0.1 pM was incubated at 21°C for 20 min in binding buffer (50 mM KCl, 0.5 mM EDTA, 10 mM Tris-HCl (pH 7.9), 1 mM DTT, 0.04% Nonidet P-40, 5% glycerol and 1 µg poly(dI-dC)) with nuclear protein extracts (3 µg). In each case the reaction mixtures were analyzed on 5% non-denaturing acrylamide gels followed by evaluation with an image analyzer (21).
Down-regulation of PKC
Human gingival fibroblasts were treated with PMA (100 nM) for 18 h to induce depletion of PKC, as described previously (22) .
Statistical analysis
All values are expressed as means ± S.E.M. Statistical analysis was performed using the PRISM software package. The results were evaluated by Dunnett's post-test and Welch's t-test. Values were considered significant at P < 0.01.
Results
First, the effect of the PKC activator PMA on PGE 2 release from human gingival fibroblasts was examined and compared with the effect of IL-1β. When human gingival fibroblasts were stimulated with PMA (100 nM) for 12 h, PGE 2 release was increased, as induced by IL-1β (1 ng/ml) (Fig. 1) .
We have previously demonstrated that IL-1β-mediated PGE 2 release is a consequence of COX-2 mRNA induction in human gingival fibroblasts (8) . Therefore, the effect of PMA on COX-2 mRNA expression was examined by RT-PCR. As Fig. 2 shows, PMA stimulated the expression of COX-2 mRNA to an extent comparable to that of IL-1β in human gingival fibroblasts treated with drugs for 6 h.
NFκB is a critical transcription factor involved in the transcriptional control of COX-2 gene expression (6) . To examine the binding of the NFκB sequence to nuclear proteins, COX-2-NFκB oligonucleotide was end-labeled and incubated with aliquots of nuclear proteins extracted from human gingival fibroblasts treated with IL-1β or PMA for 60 min. IL-1β clearly stimulated the formation of COX-2-NFκB DNA-protein complex, but less PMA, as Fig. 3 summarizes. On the other hand, the effects of IL-1β and PMA on the formation of COX-2-NFκB DNAprotein complex were examined in cells where PMAsensitive PKC activity was down-regulated. As Fig. 3 shows, IL-1β stimulated the formation of COX-2-NFκB DNA-protein complex, but PMA failed to do so in the PKCdownregulated cells. In the PKC-downregulated cells, IL-1β-stimulated PGE 2 release occurred, but PMA-induced PGE 2 release was reduced, as shown in Fig. 4 . These observations suggest that PMA-sensitive PKC or PKC itself is less involved in COX-2 expression via NFκB activation induced by IL-1β in human gingival fibroblasts.
We then examined the effect of PKC inhibitors. The PKC family consists of at least 10 members, which are divided into three groups on the basis of their structural characteristics and cofactor requirements: the classical PKC (cPKC), the novel PKC (nPKC) and the atypical PKC (aPKC) isoforms (26) . As Fig. 5 shows, Gö6983 (10 µM), an aPKC inhibitor (27) , clearly inhibited the formation of COX-2-NFκB DNA-protein complex induced by IL-1β, whereas Gö6976 (10 µM), an inhibitor of cPKC and nPKC (28,29), did not. Next, the effects of inhibitors on IL-1β-stimulated PGE 2 release were examined. As Fig. 6 shows, IL-1β-induced PGE 2 release was clearly reduced in the presence of Gö6983, but not in the presence of Gö6976. Fig. 1 IL-1β -or PMA-induced PGE 2 release. Human gingival fibroblasts were treated with IL-1β (1 ng/ml) or PMA (100 nM) for 12 h. After incubation, PGE 2 levels in the media were measured by an enzyme immunoassay. Values are expressed as means ± S.E.M. of 4-6 independent experiments. ** P < 0.01, significant differences from the control using analysis of variance followed by Dunnett's post-test. These results suggest that aPKC is involved in transcriptional control of COX-2 via NFκB activation, which consequently regulates IL-1β-induced PGE 2 synthesis in human gingival fibroblasts.
Discussion
The pro-inflammatory cytokine IL-1β enhances PGE 2 synthesis in human gingival fibroblasts. However, the signaling pathways implicated in IL-1β-induced PGE 2 synthesis are not well understood. In this study, the involvement of PKC in IL-1β-induced PGE 2 release via COX-2 expression in human gingival fibroblasts was demonstrated.
In human gingival fibroblasts, PMA, a known direct PKC activator, mimicked the effect of IL-1β on COX-2 mRNA expression and PGE 2 release. These results suggest that PMA-activated PKC is involved in PGE 2 release via COX-2 expression.
The NFκB transcription factors play key roles in regulating the expression of a variety of genes involved in immune and inflammatory responses, cell proliferation, and apoptosis (27) . In human gingival fibroblasts, proinflammatory cytokines such as IL-1β and TNF-α, which play a major role in inflammation, rapidly induce NFκB activation and cause up-regulation of NFκB-dependent genes, including COX-2 (8,9). However, PMA had a less marked stimulatory effect on the formation of COX-2-NFκB-DNA complex, whereas IL-1β had a clearly stimulatory effect. In the PMA-dependent PKC-downregulated cells, PMA failed to induce the formation of COX-2-NFκB-DNA complex, whereas IL-1β induced sufficient stimulation. These observations suggest that PMAstimulated PKC or PKC itself is less involved in COX-2 expression via NFκB activation induced by IL-1β although the PMA-sensitive PKC pathway appears to contribute to Fig. 3 IL-1β -and PMA-induced DNA binding activity recognizing the NFκB sequence in normal and PKCdown-regulated human gingival fibroblasts. Human gingival fibroblasts were treated with (DR) or without (Cont) PMA (100 nM) for 18 h to induce the downregulation of PKC. Then nuclear protein extracts were isolated from the cells further treated with IL-1β (1 ng/ml) or PMA (100 nM) for 60 min. Radiolabeled double-stranded COX-2-NFκB was incubated for 20 min at 21°C with a nuclear protein extract (5 µg). DNA-protein complexes were separated on 5% polyacrylamide in low-strength Tris borate buffer, dried under vacuum, and exposed to an imaging plate for quantitation using an image analyzer. Results are representative of three independent experiments. experiments. ** P < 0.01, significant differences from the control using analysis of variance followed by Welch's t-test.
PGE 2 release via COX-2 mRNA expression induced by factors other than IL-1β. The PKC family is composed of at least 10 members, which are divided into three subgroups based on their structural characteristics and cofactor requirements. They include the classical PKC (cPKC; α, βI, βII and γ), the novel PKC (nPKC; δ, ε, η and θ), and the atypical PKC (aPKC; ζ and ι/λ) isoforms (28) . All isoforms require phosphatidylserine, a component of the phospholipid bilayer, for their activation. The cPKCs are Ca 2+ -sensitive and also require diacylglycerol (DAG) or tumor-promoting phorbol esters for their activation. The nPKCs are Ca 2+ -independent but still require DAG or phorbol esters (29, 30) . The aPKCs are also Ca 2+ -independent, and phosphatidylserine is sufficient for their maximal activity (31) .
In this study, it was demonstrated that PMA has a very weak effect on the formation of COX-2-NFκB-DNA complex in human gingival fibroblasts. Furthermore, the IL-1β response is Ca 2+ -independent in human gingival fibroblasts, because IL-1β had no effect on Ca 2+ mobilization (32) . Therefore, the possibility that Ca 2+ -and PMA-independent PKC contributes to the formation of COX-2-NFκB-DNA complex induced by IL-1β was considered. In fact, the effect of IL-1β on the formation of COX-2-NFκB-DNA complex was inhibited by the aPKC inhibitor Gö6983, but not by the inhibitor of cPKC and nPKC, Gö6976. Taken together, it is conceivable that aPKC is involved in the effect of IL-1β on formation of the COX-2-NFκB-DNA complex.
Even in cells where PMA-sensitive PKC was downregulated, IL-1β stimulated the formation of COX-2-NFκB-DNA complex and simultaneously induced PGE 2 release. Furthermore, in the presence of the aPKC inhibitor, the effect of IL-1β on formation of the COX-2-NFκB-DNA complex was reduced, simultaneously with that on PGE 2 release. These observations suggest that aPKC contributes to COX-2 expression via NFκB activation induced by IL-1β and subsequently regulates PGE 2 synthesis and release in human gingival fibroblasts. Fig. 5 The effect of PKC inhibitors on IL-1β-induced DNAcomplex formation. Human gingival gingival fibrolasts were preincubated with PKC inhibitors (Gö6976 10 µM, Gö6983 10 µM) for 30 min, and then incubated with IL-1β (1 ng/ml) for 60 min. Nuclear protein extracts were obtained from the cells. Radiolabeled doublestranded COX-2-NFκB was incubated for 20 min at 21°C with the nuclear protein extract (5 µg). DNAprotein complexes were separated on 5% polyacrylamide in low-strength Tris borate buffer, dried under vacuum, and exposed to an imaging plate for quantitation using an image analyzer. Results are representative of three independent experiments. Fig.6 Effect of PKC inhibitors on IL-1β-induced PGE 2 release. Human gingival fibroblasts were preincubated with PKC inhibitors (Gö6976 10 µM, Gö6983 10 µM ) for 30 min, and then incubated with IL-1β (1 ng/ml) in for 6 h. After incubation, PGE 2 levels in the media were measured by an enzyme immunoassay. Values are represented as a percentage of IL-1β. Values are expressed as means ± S.E.M. of 4-6 independent experiments. ** P < 0.01, significant differences from the control using analysis of variance followed by Dunnett's test.
aPKC consists of ζ and ι/λ isoforms (33) . Recently, it has been reported that PKCζ is involved in COX-2 expression in smooth muscle cells and platelets (22, 34) . Further experiments will be required to confirm which isozyme predominates in the transactivation of the COX-2 gene in response to IL-1β in human gingival fibroblasts.
In conclusion, it has been demonstrated that aPKC is involved in the effect of IL-1β on PGE 2 synthesis via the formation of COX-2-NFκB-DNA complex in human gingival fibroblasts, which appears to be related to inflammation in gingival tissues.
